Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin J Barrett

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Current Opinion in Hematology|August 18, 2017
The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomesKate Stringaris, Austin J Barrett
Therapeutic Advances in Hematology|February 3, 2016
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Kazusa Ishii, Austin J Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and LeukemiaGreg D Whitehill, Shoba Amarnath, Pawel Muranski, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|November 9, 2002
A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipientsSunday O Akintoye, Michael T Brennan, Christopher J Graber, et al.
Leukemia Research Reports|August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infectionSheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Stem Cells (Dayton, Ohio)|December 24, 2014
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivoShoba Amarnath, Jason E Foley, Don E Farthing, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Current Opinion in Hematology|August 18, 2017
The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomesKate Stringaris, Austin J Barrett
Therapeutic Advances in Hematology|February 3, 2016
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Kazusa Ishii, Austin J Barrett
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and LeukemiaGreg D Whitehill, Shoba Amarnath, Pawel Muranski, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|November 9, 2002
A retrospective investigation of advanced periodontal disease as a risk factor for septicemia in hematopoietic stem cell and bone marrow transplant recipientsSunday O Akintoye, Michael T Brennan, Christopher J Graber, et al.
Leukemia Research Reports|August 11, 2017
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated <i>Fusarium solani</i> infectionSheenu Sheela, Sawa Ito, Jeffrey R Strich, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Stem Cells (Dayton, Ohio)|December 24, 2014
Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivoShoba Amarnath, Jason E Foley, Don E Farthing, et al.
Pageof 1